Nevertheless it's an oral drug and probably because of that, it commanded such a high valuation (?). I look at the RCPT chart, it started with a market cap of less than $500 mil in 2014 and ballooned to $6 bil in 2015 ??? Wow. Or did it had a reverse split ??